Mr Robert Hutchins, Consultant Liver, Biliary and Pancreatic Surgeon

Barts and the London NHS Trust, London Bridge Hospital
Published January 11th, 2012 | Last updated April 23rd, 2012
Make an appointment Ask a question

Mr Robert Hutchins is a Consultant Liver, Biliary and Pancreatic Surgeon based at St Bartholomew’s and the Royal London Hospitals who sees patients privately at the London Bridge Hospital. He qualified as a doctor (MB BS) from the Medical College of St Bartholomew’s Hospital and trained in liverA large abdominal organ that has many important roles including the production of bile and clotting factors, detoxification, and the metabolism of proteins, carbohydrates and fats. surgery and transplantation in Cambridge, the Royal Free Hospital, London and the Hammersmith Hospital, London. He became a Fellow of the Royal College of Surgeons of England in 1995 and completed his specialist training in liver and pancreaticRelating to the pancreas. surgery in 2001.

Mr Hutchins is a member of the National Cancer Peer Review Team which oversees quality control in the treatment of patients with cancers of the pancreasA gland behind the stomach that produces digestive enzymes and the hormones insulin and glucagon, which together regulate glucose levels in the blood. and liver in the UK. He is a Senior Lecturer at the Institute of Cancer in London and has a research interest in the development of new anti-cancer drugs and the molecular and geneticRelating to the genes, the basic units of genetic material. understanding of cancer.

Mr Hutchins has been practising as a Consultant Liver and Pancreatic Surgeon since 2002 and has performed over 400 liver resections and over 250 pancreatic resections.

Personal treatment philosophy: I firmly believe in an all-inclusive philosophy to cancer care with all patients receiving the opportunity to discuss or have available every treatment option available. I personally have an aggressive surgical approach to cancers of this region.
 

Articles: 

  • Treating secondary liver cancer

    By Mr Robert Hutchins, Consultant Liver, Biliary and Pancreatic SurgeonContact
    Barts and the London NHS Trust, London Bridge Hospital

    Despite often having very successful treatment of a primary cancerAbnormal, uncontrolled cell division resulting in a malignant tumour that may invade surrounding tissues or spread to distant parts of the body., unfortunately many patients will go on to develop secondary cancerA tumour or abnormal swelling that results from the spread of another malignant (uncontrolled) tumour to a distant part of the body. in other sites around the body such as the bones, lungs and liverA large abdominal organ that has many important roles including the production of bile and clotting factors, detoxification, and the metabolism of proteins, carbohydrates and fats.. The most dangerous time for development of secondary disease is the first two years after diagnosisThe process of determining which condition a patient may have., although sometimes the disease will have already spread by the time that the cancer is diagnosed. The development of secondary disease is a feature of the aggressiveness and ability of the primary cancer to spread beyond its original site and this does not reflect any failure on behalf of surgical treatment or subsequent chemotherapyThe use of chemical substances to treat disease, particularly cancer. or radiotherapyThe treatment of disease using radiation. treatments.

Continuous improvement requires feedback and your opinions count. Do you have a few minutes to tell us what you think about this site?

Yes
No